Hepcdac (60 mg)

CIPLA LTD.

HEPCDAC contains Drug / Molecule “DACLATASVIR”. Hepcdac 60 mg Tablet is used in combination with other medications such as sofosbuvir, interferon and ribavirin for the treatment of hepatitis C infection.

Category:

Indication

HEPCDAC is used with sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection.

Note

Precaution

Hepcdac is a prescription drug and should be used under proper medical guidance and advice.

Related products